世界の補助療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Adjuvant Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3765 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、補助療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、ホルモン療法、その他）、用途別市場規模（病院、医療機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・補助療法の市場動向 ・企業の競争状況、市場シェア ・補助療法の種類別市場規模と予測2016-2027（化学療法、放射線療法、ホルモン療法、その他） ・補助療法の用途別市場規模と予測2016-2027（病院、医療機関、その他） ・補助療法の北米市場規模2016-2027（アメリカ、カナダ） ・補助療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・補助療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・補助療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・補助療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Bayer、Johnson & Johnson、AstraZenca、Mylan、AbbVie、Novartis） ・結論

Adjuvant therapy is defined as the treatment given in addition to the primary (initial) treatment. In other words it is an additional treatment that is designed to help to reach the ultimate goal.

Market Analysis and Insights: Global Adjuvant Therapy Market
The global Adjuvant Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Adjuvant Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Adjuvant Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Adjuvant Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Adjuvant Therapy market.

Global Adjuvant Therapy Scope and Market Size
Adjuvant Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Adjuvant Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Radiotherapy
Hormonotherapy
Others

Segment by Application
Hospital
Medical Institution
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
Bayer
Johnson & Johnson
AstraZenca
Mylan
AbbVie
Novartis

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adjuvant Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiotherapy
1.2.4 Hormonotherapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Adjuvant Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Medical Institution
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Adjuvant Therapy Market Perspective (2016-2027)
2.2 Adjuvant Therapy Growth Trends by Regions
2.2.1 Adjuvant Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Adjuvant Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Adjuvant Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Adjuvant Therapy Industry Dynamic
2.3.1 Adjuvant Therapy Market Trends
2.3.2 Adjuvant Therapy Market Drivers
2.3.3 Adjuvant Therapy Market Challenges
2.3.4 Adjuvant Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Adjuvant Therapy Players by Revenue
3.1.1 Global Top Adjuvant Therapy Players by Revenue (2016-2021)
3.1.2 Global Adjuvant Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Adjuvant Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Adjuvant Therapy Revenue
3.4 Global Adjuvant Therapy Market Concentration Ratio
3.4.1 Global Adjuvant Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adjuvant Therapy Revenue in 2020
3.5 Adjuvant Therapy Key Players Head office and Area Served
3.6 Key Players Adjuvant Therapy Product Solution and Service
3.7 Date of Enter into Adjuvant Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Adjuvant Therapy Breakdown Data by Type
4.1 Global Adjuvant Therapy Historic Market Size by Type (2016-2021)
4.2 Global Adjuvant Therapy Forecasted Market Size by Type (2022-2027)

5 Adjuvant Therapy Breakdown Data by Application
5.1 Global Adjuvant Therapy Historic Market Size by Application (2016-2021)
5.2 Global Adjuvant Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Adjuvant Therapy Market Size (2016-2027)
6.2 North America Adjuvant Therapy Market Size by Type
6.2.1 North America Adjuvant Therapy Market Size by Type (2016-2021)
6.2.2 North America Adjuvant Therapy Market Size by Type (2022-2027)
6.2.3 North America Adjuvant Therapy Market Size by Type (2016-2027)
6.3 North America Adjuvant Therapy Market Size by Application
6.3.1 North America Adjuvant Therapy Market Size by Application (2016-2021)
6.3.2 North America Adjuvant Therapy Market Size by Application (2022-2027)
6.3.3 North America Adjuvant Therapy Market Size by Application (2016-2027)
6.4 North America Adjuvant Therapy Market Size by Country
6.4.1 North America Adjuvant Therapy Market Size by Country (2016-2021)
6.4.2 North America Adjuvant Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Adjuvant Therapy Market Size (2016-2027)
7.2 Europe Adjuvant Therapy Market Size by Type
7.2.1 Europe Adjuvant Therapy Market Size by Type (2016-2021)
7.2.2 Europe Adjuvant Therapy Market Size by Type (2022-2027)
7.2.3 Europe Adjuvant Therapy Market Size by Type (2016-2027)
7.3 Europe Adjuvant Therapy Market Size by Application
7.3.1 Europe Adjuvant Therapy Market Size by Application (2016-2021)
7.3.2 Europe Adjuvant Therapy Market Size by Application (2022-2027)
7.3.3 Europe Adjuvant Therapy Market Size by Application (2016-2027)
7.4 Europe Adjuvant Therapy Market Size by Country
7.4.1 Europe Adjuvant Therapy Market Size by Country (2016-2021)
7.4.2 Europe Adjuvant Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Adjuvant Therapy Market Size (2016-2027)
8.2 Asia-Pacific Adjuvant Therapy Market Size by Type
8.2.1 Asia-Pacific Adjuvant Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Adjuvant Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Adjuvant Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Adjuvant Therapy Market Size by Application
8.3.1 Asia-Pacific Adjuvant Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Adjuvant Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Adjuvant Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Adjuvant Therapy Market Size by Region
8.4.1 Asia-Pacific Adjuvant Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Adjuvant Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Adjuvant Therapy Market Size (2016-2027)
9.2 Latin America Adjuvant Therapy Market Size by Type
9.2.1 Latin America Adjuvant Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Adjuvant Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Adjuvant Therapy Market Size by Type (2016-2027)
9.3 Latin America Adjuvant Therapy Market Size by Application
9.3.1 Latin America Adjuvant Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Adjuvant Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Adjuvant Therapy Market Size by Application (2016-2027)
9.4 Latin America Adjuvant Therapy Market Size by Country
9.4.1 Latin America Adjuvant Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Adjuvant Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Adjuvant Therapy Market Size (2016-2027)
10.2 Middle East & Africa Adjuvant Therapy Market Size by Type
10.2.1 Middle East & Africa Adjuvant Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Adjuvant Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Adjuvant Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Adjuvant Therapy Market Size by Application
10.3.1 Middle East & Africa Adjuvant Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Adjuvant Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Adjuvant Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Adjuvant Therapy Market Size by Country
10.4.1 Middle East & Africa Adjuvant Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Adjuvant Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Adjuvant Therapy Introduction
11.1.4 Merck Revenue in Adjuvant Therapy Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Adjuvant Therapy Introduction
11.2.4 Bayer Revenue in Adjuvant Therapy Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Adjuvant Therapy Introduction
11.3.4 Johnson & Johnson Revenue in Adjuvant Therapy Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 AstraZenca
11.4.1 AstraZenca Company Details
11.4.2 AstraZenca Business Overview
11.4.3 AstraZenca Adjuvant Therapy Introduction
11.4.4 AstraZenca Revenue in Adjuvant Therapy Business (2016-2021)
11.4.5 AstraZenca Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Mylan Business Overview
11.5.3 Mylan Adjuvant Therapy Introduction
11.5.4 Mylan Revenue in Adjuvant Therapy Business (2016-2021)
11.5.5 Mylan Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Adjuvant Therapy Introduction
11.6.4 AbbVie Revenue in Adjuvant Therapy Business (2016-2021)
11.6.5 AbbVie Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Adjuvant Therapy Introduction
11.7.4 Novartis Revenue in Adjuvant Therapy Business (2016-2021)
11.7.5 Novartis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Adjuvant Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiotherapy
Table 4. Key Players of Hormonotherapy
Table 5. Key Players of Others
Table 6. Global Adjuvant Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Adjuvant Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Adjuvant Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Adjuvant Therapy Market Share by Regions (2016-2021)
Table 10. Global Adjuvant Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Adjuvant Therapy Market Share by Regions (2022-2027)
Table 12. Adjuvant Therapy Market Trends
Table 13. Adjuvant Therapy Market Drivers
Table 14. Adjuvant Therapy Market Challenges
Table 15. Adjuvant Therapy Market Restraints
Table 16. Global Adjuvant Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Adjuvant Therapy Market Share by Players (2016-2021)
Table 18. Global Top Adjuvant Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adjuvant Therapy as of 2020)
Table 19. Ranking of Global Top Adjuvant Therapy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Adjuvant Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Adjuvant Therapy Product Solution and Service
Table 23. Date of Enter into Adjuvant Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Adjuvant Therapy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Adjuvant Therapy Revenue Market Share by Type (2016-2021)
Table 27. Global Adjuvant Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Adjuvant Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Adjuvant Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Adjuvant Therapy Revenue Market Share by Application (2016-2021)
Table 31. Global Adjuvant Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Adjuvant Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Adjuvant Therapy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Adjuvant Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Adjuvant Therapy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Adjuvant Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Adjuvant Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Adjuvant Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Adjuvant Therapy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Adjuvant Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Adjuvant Therapy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Adjuvant Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Adjuvant Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Adjuvant Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Adjuvant Therapy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Adjuvant Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Adjuvant Therapy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Adjuvant Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Adjuvant Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Adjuvant Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Adjuvant Therapy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Adjuvant Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Adjuvant Therapy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Adjuvant Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Adjuvant Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Adjuvant Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Adjuvant Therapy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Adjuvant Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Adjuvant Therapy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Adjuvant Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Adjuvant Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Adjuvant Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 63. Merck Company Details
Table 64. Merck Business Overview
Table 65. Merck Adjuvant Therapy Product
Table 66. Merck Revenue in Adjuvant Therapy Business (2016-2021) & (US$ Million)
Table 67. Merck Recent Development
Table 68. Bayer Company Details
Table 69. Bayer Business Overview
Table 70. Bayer Adjuvant Therapy Product
Table 71. Bayer Revenue in Adjuvant Therapy Business (2016-2021) & (US$ Million)
Table 72. Bayer Recent Development
Table 73. Johnson & Johnson Company Details
Table 74. Johnson & Johnson Business Overview
Table 75. Johnson & Johnson Adjuvant Therapy Product
Table 76. Johnson & Johnson Revenue in Adjuvant Therapy Business (2016-2021) & (US$ Million)
Table 77. Johnson & Johnson Recent Development
Table 78. AstraZenca Company Details
Table 79. AstraZenca Business Overview
Table 80. AstraZenca Adjuvant Therapy Product
Table 81. AstraZenca Revenue in Adjuvant Therapy Business (2016-2021) & (US$ Million)
Table 82. AstraZenca Recent Development
Table 83. Mylan Company Details
Table 84. Mylan Business Overview
Table 85. Mylan Adjuvant Therapy Product
Table 86. Mylan Revenue in Adjuvant Therapy Business (2016-2021) & (US$ Million)
Table 87. Mylan Recent Development
Table 88. AbbVie Company Details
Table 89. AbbVie Business Overview
Table 90. AbbVie Adjuvant Therapy Product
Table 91. AbbVie Revenue in Adjuvant Therapy Business (2016-2021) & (US$ Million)
Table 92. AbbVie Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Adjuvant Therapy Product
Table 96. Novartis Revenue in Adjuvant Therapy Business (2016-2021) & (US$ Million)
Table 97. Novartis Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adjuvant Therapy Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiotherapy Features
Figure 4. Hormonotherapy Features
Figure 5. Others Features
Figure 6. Global Adjuvant Therapy Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Medical Institution Case Studies
Figure 9. Others Case Studies
Figure 10. Adjuvant Therapy Report Years Considered
Figure 11. Global Adjuvant Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Adjuvant Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Adjuvant Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global Adjuvant Therapy Market Share by Regions (2022-2027)
Figure 15. Global Adjuvant Therapy Market Share by Players in 2020
Figure 16. Global Top Adjuvant Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adjuvant Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Adjuvant Therapy Revenue in 2020
Figure 18. Global Adjuvant Therapy Revenue Market Share by Type (2016-2021)
Figure 19. Global Adjuvant Therapy Revenue Market Share by Type (2022-2027)
Figure 20. North America Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Adjuvant Therapy Market Share by Type (2016-2027)
Figure 22. North America Adjuvant Therapy Market Share by Application (2016-2027)
Figure 23. North America Adjuvant Therapy Market Share by Country (2016-2027)
Figure 24. United States Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Adjuvant Therapy Market Share by Type (2016-2027)
Figure 28. Europe Adjuvant Therapy Market Share by Application (2016-2027)
Figure 29. Europe Adjuvant Therapy Market Share by Country (2016-2027)
Figure 30. Germany Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Adjuvant Therapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Adjuvant Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Adjuvant Therapy Market Share by Region (2016-2027)
Figure 40. China Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Adjuvant Therapy Market Share by Type (2016-2027)
Figure 48. Latin America Adjuvant Therapy Market Share by Application (2016-2027)
Figure 49. Latin America Adjuvant Therapy Market Share by Country (2016-2027)
Figure 50. Mexico Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Adjuvant Therapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Adjuvant Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Adjuvant Therapy Market Share by Country (2016-2027)
Figure 56. Turkey Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Adjuvant Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Merck Revenue Growth Rate in Adjuvant Therapy Business (2016-2021)
Figure 60. Bayer Revenue Growth Rate in Adjuvant Therapy Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Adjuvant Therapy Business (2016-2021)
Figure 62. AstraZenca Revenue Growth Rate in Adjuvant Therapy Business (2016-2021)
Figure 63. Mylan Revenue Growth Rate in Adjuvant Therapy Business (2016-2021)
Figure 64. AbbVie Revenue Growth Rate in Adjuvant Therapy Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Adjuvant Therapy Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---